U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

E&BI Monitoring Program Lead US

Regulatory Compliance & EthicsUpdated on Nov 14
Full-timeAtlanta, GA, USA$126k - $165k

About the Job

Requirements

  • A bachelor's degree or higher in a relevant field.
  • At least 5 years of experience in United States healthcare compliance or risk management.

Responsibilities

  • Develop and refine monitoring strategies and annual plans in line with business needs.
  • Collaborate with regional leads to align monitoring with local regulations.
  • Oversee and manage external vendors for Ethics & Business Integrity monitoring activities.
  • Report monitoring activities, findings, and trends to senior leadership.
  • Manage High Impact Findings and drive continuous improvement.
  • Use analytics tools to provide actionable insights.

Desired Qualifications

  • At least 2 years in a leadership or managerial role.
  • Experience leading teams or managing vendors in a multinational environment.
  • Expertise in global healthcare regulatory standards and compliance analytics.
  • Relevant professional certifications, such as CCEP, CFE, CPA, CHC, or CCEP-I.
  • Experience with advanced analytics tools such as Qlik or Power BI.
  • Project management skills.
  • Experience presenting to senior leadership and external stakeholders.
  • Ability to adapt monitoring plans to diverse regulatory environments.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs